Performance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer’s disease

BACKGROUND: The recent promise of disease-modifying therapies for Alzheimer’s disease (AD) has reinforced the need for accurate biomarkers for early disease detection, diagnosis and treatment monitoring. Advances in the development of novel blood-based biomarkers for AD have revealed that plasma lev...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilson, Edward N., Young, Christina B., Ramos Benitez, Javier, Swarovski, Michelle S., Feinstein, Igor, Vandijck, Manu, Le Guen, Yann, Kasireddy, Nandita M., Shahid, Marian, Corso, Nicole K., Wang, Qian, Kennedy, Gabriel, Trelle, Alexandra N., Lind, Betty, Channappa, Divya, Belnap, Malia, Ramirez, Veronica, Skylar-Scott, Irina, Younes, Kyan, Yutsis, Maya V., Le Bastard, Nathalie, Quinn, Joseph F., van Dyck, Christopher H., Nairn, Angus, Fredericks, Carolyn A., Tian, Lu, Kerchner, Geoffrey A., Montine, Thomas J., Sha, Sharon J., Davidzon, Guido, Henderson, Victor W., Longo, Frank M., Greicius, Michael D., Wagner, Anthony D., Wyss-Coray, Tony, Poston, Kathleen L., Mormino, Elizabeth C., Andreasson, Katrin I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652927/
https://www.ncbi.nlm.nih.gov/pubmed/36371232
http://dx.doi.org/10.1186/s13195-022-01116-2

Ejemplares similares

Ejemplares similares